Cargando…

Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication

Combination antidepressant pharmacotherapies are frequently used to treat major depressive disorder (MDD). However, there is no evidence that machine learning approaches combining multi-omics measures (e.g., genomics and plasma metabolomics) can achieve clinically meaningful predictions of outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joyce, Jeremiah B., Grant, Caroline W., Liu, Duan, MahmoudianDehkordi, Siamak, Kaddurah-Daouk, Rima, Skime, Michelle, Biernacka, Joanna, Frye, Mark A., Mayes, Taryn, Carmody, Thomas, Croarkin, Paul E., Wang, Liewei, Weinshilboum, Richard, Bobo, William V., Trivedi, Madhukar H., Athreya, Arjun P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497535/ https://www.ncbi.nlm.nih.gov/pubmed/34620827 http://dx.doi.org/10.1038/s41398-021-01632-z

Ejemplares similares

Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder
por: Grant, Caroline W., et al.
Publicado: (2022)

Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder
por: Grant, Caroline W., et al.
Publicado: (2022)

Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings
por: Athreya, Arjun P., et al.
Publicado: (2021)

Pharmacogenomics‐Driven Prediction of Antidepressant Treatment Outcomes: A Machine‐Learning Approach With Multi‐trial Replication
por: Athreya, Arjun P., et al.
Publicado: (2019)

Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants
por: Athreya, Arjun P., et al.
Publicado: (2022)

Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids
por: MahmoudianDehkordi, Siamak, et al.
Publicado: (2022)

Addressing adherence to antidepressant treatment for depression
por: Mayes, Taryn L., et al.
Publicado: (2020)

Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression
por: MahmoudianDehkordi, Siamak, et al.
Publicado: (2021)

Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients
por: Bhattacharyya, Sudeepa, et al.
Publicado: (2019)

Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics
por: Liu, Duan, et al.
Publicado: (2018)

Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment
por: Bhattacharyya, Sudeepa, et al.
Publicado: (2019)

Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
por: Nho, Kwangsik, et al.
Publicado: (2021)

ERICH3: vesicular association and antidepressant treatment response
por: Liu, Duan, et al.
Publicado: (2020)

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics
por: Gupta, M, et al.
Publicado: (2016)

Metabolic Profiling of Patients with Schizophrenia
por: Kaddurah-Daouk, Rima
Publicado: (2006)

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
por: Nho, Kwangsik, et al.
Publicado: (2019)

The 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR(9)) measure of suicidal risk: Performance in adult primary care patients
por: Nandy, Karabi, et al.
Publicado: (2023)

Peripheral serum metabolomic profiles inform central cognitive impairment
por: Wang, Jingye, et al.
Publicado: (2020)

Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature
por: Brydges, Christopher R., et al.
Publicado: (2021)

Considering depression as a secondary outcome in the optimization of physical activity interventions for breast cancer survivors in the PACES trial: a factorial randomized controlled trial
por: Rethorst, Chad D., et al.
Publicado: (2023)

The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients
por: Nandy, Karabi, et al.
Publicado: (2022)

Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder
por: Ho, Ming-Fen, et al.
Publicado: (2022)

Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
por: Nguyen, Thanh Thanh L., et al.
Publicado: (2021)

The effectiveness of enhanced evidence-based care for depressive disorders: a meta-analysis of randomized controlled trials
por: Xiao, Le, et al.
Publicado: (2021)

Module-Based Association Analysis for Omics Data with Network Structure
por: Wang, Zhi, et al.
Publicado: (2015)

PISTACHIo (PreemptIon of diSrupTive behAvior in CHIldren): real-time monitoring of sleep and behavior of children 3–7 years old receiving parent–child interaction therapy augment with artificial intelligence — the study protocol, pilot study
por: Saliba, Maria, et al.
Publicado: (2023)

Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
por: Beger, Richard D., et al.
Publicado: (2020)

Epigenetic regulation of GABA catabolism in iPSC-derived neurons: The molecular links between FGF21 and histone methylation
por: Ho, Ming-Fen, et al.
Publicado: (2023)

An electronic health record driven algorithm to identify incident antidepressant medication users
por: Bobo, William V, et al.
Publicado: (2014)

Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer
por: Athreya, Arjun P., et al.
Publicado: (2017)

Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer’s Disease
por: Baloni, Priyanka, et al.
Publicado: (2020)

Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts
por: Ward, Joey, et al.
Publicado: (2018)

Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data
por: Duong, Stephanie Q., et al.
Publicado: (2022)

A review of quetiapine in combination with antidepressant therapy in patients with depression
por: Daly, Ella J, et al.
Publicado: (2007)

Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study
por: Ho, Ming‐Fen, et al.
Publicado: (2022)

Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012)

Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR(16)) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized Trial
por: Trombello, Joseph M, et al.
Publicado: (2023)

Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
por: Jha, Manish K., et al.
Publicado: (2018)

Preliminary Evidence for Anhedonia as a Marker of Sexual Trauma in Female Adolescents
por: Sonmez, Ayse Irem, et al.
Publicado: (2021)

Metformin Pharmacogenomics: Biomarkers to Mechanisms
por: Wang, Liewei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n398b53go5fatierttkg7kqnqb